Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database

Pharmacoepidemiology and Drug Safety
Benjamin G FinckeDavid R Gagnon

Abstract

To develop and compare three operational definitions of polypharmacy using a large prescription database. We defined Cumulative polypharmacy as all prescriptions filled during a 178 day window--which captured 95% of eventual refills as calculated from Kaplan-Meier and cumulative incidence curves. Continuous polypharmacy was all prescriptions filled in two such windows 6 months apart. Simultaneous polypharmacy was the number of prescriptions active on a particular day, as determined by fill dates and amount of medication given. We applied these definitions to the outpatient prescription files of New England veterans and compared the resulting estimates of polypharmacy using descriptive statistics. 118,013 patients received at least one prescription between January 1998 and July 1999. Cumulative polypharmacy averaged 3.54 (SD = 4.95) medications and continuous polypharmacy averaged 1.96 (SD = 3.23). Examination of simultaneous polypharmacy over 40 2-week intervals revealed an average of 2.63 (CI 2.61-2.65), a minimum of 1.09 (CI 1.08-1.10) and maximum of 4.94 (CI 4.92-4.96). One arbitrarily selected observation point had an average of 3.87 (SD = 3.17). Our definitions of cumulative and continuous polypharmacy serve to set upper a...Continue Reading

References

May 1, 1994·Australian Family Physician·N Abraham
May 1, 1993·Journal of General Internal Medicine·C A Colley, L M Lucas
May 1, 1997·Journal of Clinical Epidemiology·H S LauA Porsius
Jan 1, 1997·European Journal of Clinical Pharmacology·L BjerrumJ Kragstrup
May 26, 1998·JAMA : the Journal of the American Medical Association·J AvornJ LeLorier
Jul 29, 1998·European Journal of Clinical Pharmacology·L BjerrumJ Kragstrup
Aug 5, 1998·Menopause : the Journal of the North American Menopause Society·B R Motheral, K A Fairman
Apr 24, 1999·British Journal of Clinical Pharmacology·C OlesenU Bergman
Feb 29, 2000·American Journal of Obstetrics and Gynecology·D A HillA Z LaCroix
Aug 16, 2000·Scandinavian Journal of Primary Health Care·L Bjerrum, U Bergman

❮ Previous
Next ❯

Citations

Mar 29, 2013·European Journal of Clinical Pharmacology·Carlotta FranchiAlessandro Nobili
May 29, 2009·BMC Clinical Pharmacology·Bo HovstadiusGöran Petersson
Apr 17, 2012·Clinics in Geriatric Medicine·Bo Hovstadius, Göran Petersson
Jan 28, 2012·The American Journal of Geriatric Pharmacotherapy·Caitlyn T SolemA Simon Pickard
Aug 31, 2006·British Journal of Clinical Pharmacology·Kirsten K ViktilAasmund Reikvam
Sep 14, 2011·Pharmacoepidemiology and Drug Safety·Bo Hovstadius, Göran Petersson
Jan 26, 2011·Pharmacoepidemiology and Drug Safety·Alessandro NobiliLuca Merlino
Oct 2, 2009·Pharmacoepidemiology and Drug Safety·Thomas Grimmsmann, Wolfgang Himmel
May 15, 2016·BMC Research Notes·Amber M GoedkenJohn M Brooks
Jul 7, 2017·Population Health Management·Xue FengUsha Sambamoorthi
Aug 25, 2015·Therapeutic Advances in Psychopharmacology·Annica BergendalKarin Sparring Björkstén
Jun 22, 2017·The Annals of Pharmacotherapy·Xue FengUsha Sambamoorthi
Nov 30, 2018·PloS One·Paul M BakakiLawrence C Kleinman
Feb 26, 2019·Asia-Pacific Journal of Public Health·Ji-Wen LiI-Chen Lee
Mar 25, 2019·European Heart Journal. Cardiovascular Pharmacotherapy·Odilia I WoudstraBerto J Bouma
Jun 21, 2019·The Medical Journal of Australia·Amy T PageChristopher Etherton-Beer
Dec 14, 2017·Revista latino-americana de enfermagem·Hellen Lilliane da CruzDelba Fonseca Santos
Aug 2, 2020·British Journal of Clinical Pharmacology·Michael O FalsterBenjamin Daniels
Jan 1, 2008·International Journal of Psychiatry in Clinical Practice·Yoram Barak
Jun 4, 2019·European Journal of Hospital Pharmacy. Science and Practice·Yolanda BorregoRamón Morillo
Jun 27, 2020·Therapeutic Advances in Drug Safety·Mina KhezrianPhyo K Myint
Apr 4, 2017·Human Psychopharmacology·Adrian HealdM A De Hert
Jun 7, 2021·International Journal of Clinical Pharmacy·Kaeshaelya ThiruchelvamTherese Kairuz
Sep 11, 2019·Journal of the American Medical Directors Association·Rahel ErnstHeike A Bischoff-Ferrari
Jul 3, 2021·Pharmacoepidemiology and Drug Safety·Johan Van der HeydenOlivier Bruyère
Aug 10, 2021·Journal of Geriatric Oncology·Laurien HamHeidi P Fransen
Sep 11, 2021·Fundamental & Clinical Pharmacology·Jordan GuillotJulien Bezin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

QJM : Monthly Journal of the Association of Physicians
D A Gorard
© 2021 Meta ULC. All rights reserved